ArticlePharmacoEconomics - open2024

Correction: Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore.

Clarence Ong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.